🟢 Veraxa Biotech is trading 13.07% up today after appointing Raju Willener as CFO

Veraxa Biotech is trading 13.07% up at $1.73 after appointing Raju Willener as chief financial officer, effective September 4, 2026.

• He succeeds Carl von Halem and brings roughly three decades of financial leadership, including senior roles at Exentis Group AG.
• The stock gained 10.87% to $1.53 on September 3, extending its rebound from $1.35 on August 31.
• The appointment appears to be the clearest company-specific catalyst behind the rally; broader markets are weaker.